These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25621883)

  • 1. Correction: galectin-3 as a marker and potential therapeutic target in breast cancer.
    PLOS ONE Staff
    PLoS One; 2015; 10(1):e0116994. PubMed ID: 25621883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer.
    Zhang H; Luo M; Liang X; Wang D; Gu X; Duan C; Gu H; Chen G; Zhao X; Zhao Z; Liu C
    PLoS One; 2020; 15(4):e0232166. PubMed ID: 32298386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: breast cancer screening in Saudi Arabia: free but almost no takers.
    PLOS ONE Staff
    PLoS One; 2015; 10(4):e0124850. PubMed ID: 25853811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.
    Lee YH; Liu X; Qiu F; O'Connor TR; Yen Y; Ann DK
    PLoS One; 2015; 10(4):e0124853. PubMed ID: 25875848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis.
    D'Haene N; Sauvage S; Maris C; Adanja I; Mercier ML; Decaestecker C; Baum L; Salmon I
    PLoS One; 2023; 18(12):e0295736. PubMed ID: 38060508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.
    Dotan I; Roche PJ; Tamilia M; Paliouras M; Mitmaker EJ; Trifiro MA
    PLoS One; 2016; 11(6):e0158022. PubMed ID: 27309538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
    Bennani-Baiti B; Dietzel M; Baltzer PA
    PLoS One; 2016; 11(9):e0162936. PubMed ID: 27607428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer.
    Vitali F; Cohen LD; Demartini A; Amato A; Eterno V; Zambelli A; Bellazzi R
    PLoS One; 2017; 12(1):e0170363. PubMed ID: 28076436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications.
    PLOS ONE Staff
    PLoS One; 2015; 10(2):e0117740. PubMed ID: 25647507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
    Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
    PLoS One; 2019; 14(5):e0216968. PubMed ID: 31071170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor.
    Fukushima S; Endo M; Matsumoto Y; Fukushi JI; Matsunobu T; Kawaguchi KI; Setsu N; IIda K; Yokoyama N; Nakagawa M; Yahiro K; Oda Y; Iwamoto Y; Nakashima Y
    PLoS One; 2018; 13(3):e0194508. PubMed ID: 29543881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
    Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
    PLoS One; 2018; 13(1):e0191579. PubMed ID: 29342211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women.
    Wulaningsih W; Holmberg L; Abeler-Dörner L; Ng T; Rohrmann S; Van Hemelrijck M
    PLoS One; 2016; 11(8):e0161418. PubMed ID: 27512987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
    Korkola JE; Collisson EA; Heiser LM; Oates C; Bayani N; Itani S; Esch A; Thompson W; Griffith OL; Wang NJ; Kuo WL; Cooper B; Billig J; Ziyad S; Hung JL; Jakkula L; Feiler H; Lu Y; Mills GB; Spellman PT; Tomlin C; Mukherjee S; Gray JW
    PLoS One; 2017; 12(10):e0186551. PubMed ID: 29020035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    Bromberg SE; Moraes PRAF; Ades F
    PLoS One; 2018; 13(3):e0195130. PubMed ID: 29579107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    Hadjialirezaei S; Picco G; Beatson R; Burchell J; Stokke BT; Sletmoen M
    PLoS One; 2018; 13(1):e0190814. PubMed ID: 29293665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice.
    Milani M; Laranjeira AB; de Vasconcellos JF; Brandalise SR; Nowill AE; Yunes JA
    PLoS One; 2015; 10(7):e0134774. PubMed ID: 26230098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.
    The
    PLoS One; 2015; 10(2):e0117876. PubMed ID: 25658838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
    Goode G; Gunda V; Chaika NV; Purohit V; Yu F; Singh PK
    PLoS One; 2017; 12(6):e0179098. PubMed ID: 28570622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Dietary habits in adolescence and midlife and risk of breast cancer in older women.
    Haraldsdottir A; Torfadottir JE; Valdimarsdottir UA; Adami HO; Aspelund T; Tryggvadottir L; Thordardottir M; Birgisdottir BE; Harris TB; Launer LJ; Gudnason V; Steingrimsdottir L
    PLoS One; 2018; 13(10):e0206026. PubMed ID: 30321233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.